⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
UTHR News
United Therapeutics Corp
Pulmonary Arterial Hypertension Market Outlook Shows Strong Upward Trend at a CAGR of 6.7% During the Study Period (2022-2036) Supported by New Clinical Developments | DelveInsight
prnewswire.com
UTHR
LQDA
GOSS
INSM
JNJ
MRK
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026
businesswire.com
UTHR
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
businesswire.com
UTHR
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
businesswire.com
UTHR
Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease
prnewswire.com
UTHR
United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026
businesswire.com
UTHR
Unituxin (United Therapeutics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
UTHR
Form 8-K
sec.gov
UTHR
United Therapeutics Corporation Reports First Quarter 2026 Financial Results
businesswire.com
UTHR
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
globenewswire.com
MNKD
UTHR